An interdisciplinary multi-center research team led by the LKS Faculty of Medicine (HKUMed) and Faculty of Dentistry at the ...
Beyond Cancer, Ltd., a clinical stage biotechnology company developing ultra-high concentration nitric oxide (UNO) as an immunotherapeutic for solid tumors and subsidiary of Beyond Air, Inc. (NASDAQ: ...
Soft tissue sarcomas rarely metastasize to the heart, with cardiac involvement seen in less than 0.03% of cases. Metastatic heart disease presents diagnostic challenges due to nonspecific symptoms, ...
Scientists at the Icahn School of Medicine at Mount Sinai have developed an experimental immunotherapy that takes an ...
The Center for Metastasis Research eXcellence (MET-X) is an interdisciplinary and collaborative program at Fred Hutch Cancer Center focused on one of the most challenging areas of cancer biology: ...
Please provide your email address to receive an email when new articles are posted on . Five-year local recurrence rates were 10% and 17% for atypical fibroxanthoma and pleomorphic dermal sarcoma, ...
New therapy reprograms immune cells inside tumors to attack cancer, bypassing traditional cell therapy manufacturing ...
A new nano-sized drug carrier that finds bone tumors and releases treatment exactly where it's needed is here to improve the ...
Stanford University-led researchers report that tumor cells hijack mitochondria from immune cells, reducing anti-tumor immune function and activating cGAS-STING and type I interferon signaling that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results